Advanced Enzyme Technologies last traded at ₹266.00 (2026-10-13). Over the past month the stock moved -12.5%, three months the stock moved -29.4%, year the stock moved -21.7%. Its closing range over 52 weeks is ₹264.40 – ₹376.80, with the latest close 29.4% below the high.
Closing prices up to 2026-10-13.
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]
Market Position The Co. is the 1st Indian enzyme company with 2nd highest market share in India. It is the 2nd listed integrated enzyme player globally. [1]
In the latest quarter (Jun 2026), Advanced Enzyme Technologies reported sales of ₹190.00 crore (+2.2%) and net profit of ₹39.00 crore (-2.5%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 190.00 | 51.00 | 27.00 | 39.00 | 3.31 |
| Mar 2026 | 203.00 | 63.00 | 31.00 | 45.00 | 3.84 |
| Dec 2025 | 172.00 | 49.00 | 29.00 | 43.00 | 3.80 |
| Sep 2025 | 185.00 | 60.00 | 33.00 | 45.00 | 3.87 |
| Jun 2025 | 186.00 | 56.00 | 30.00 | 40.00 | 3.57 |
| Mar 2025 | 167.00 | 46.00 | 27.00 | 27.00 | 2.37 |
| Dec 2024 | 169.00 | 55.00 | 33.00 | 39.00 | 3.37 |
| Sep 2024 | 146.00 | 42.00 | 29.00 | 33.00 | 2.94 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -7.6% | +5.0% | +5.7% | +20.0% | +26.7% | +1.8% | +21.6% | +2.2% |
| Operating profit growth | -17.6% | +1.9% | -16.4% | +9.8% | +42.9% | -10.9% | +37.0% | -8.9% |
| Net profit growth | -5.7% | -7.1% | -10.0% | +14.3% | +36.4% | +10.3% | +66.7% | -2.5% |
| EPS growth | -4.5% | -9.9% | -6.3% | +17.0% | +31.6% | +12.8% | +62.0% | -7.3% |
| OPM % | 29.0% | 33.0% | 27.0% | 30.0% | 33.0% | 29.0% | 31.0% | 27.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Advanced Enzyme Technologies reported sales of ₹746.00 crore (+17.1%) and net profit of ₹174.00 crore (+29.9%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 746.00 | 229.00 | 31.00 | 174.00 | 15.07 |
| Mar 2025 | 637.00 | 196.00 | 31.00 | 134.00 | 11.72 |
| Mar 2024 | 624.00 | 206.00 | 33.00 | 137.00 | 11.92 |
| Mar 2023 | 541.00 | 158.00 | 29.00 | 104.00 | 9.45 |
| Mar 2022 | 529.00 | 203.00 | 38.00 | 124.00 | 10.70 |
| Mar 2021 | 502.00 | 233.00 | 46.00 | 151.00 | 13.06 |
| Mar 2020 | 444.00 | 203.00 | 46.00 | 133.00 | 11.58 |
| Mar 2019 | 420.00 | 184.00 | 44.00 | 116.00 | 9.95 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +7.4% | +5.7% | +13.1% | +5.4% | +2.3% | +15.3% | +2.1% | +17.1% |
| Operating profit growth | +11.5% | +10.3% | +14.8% | -12.9% | -22.2% | +30.4% | -4.9% | +16.8% |
| Net profit growth | +23.4% | +14.7% | +13.5% | -17.9% | -16.1% | +31.7% | -2.2% | +29.9% |
| EPS growth | +23.3% | +16.4% | +12.8% | -18.1% | -11.7% | +26.1% | -1.7% | +28.6% |
| OPM % | 44.0% | 46.0% | 46.0% | 38.0% | 29.0% | 33.0% | 31.0% | 31.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Advanced Enzyme Technologies.
Get Free AI Stock Analysis FREE →Advanced Enzyme gains on completing additional investment of Rs 25 lakh in ANPL
Advanced Enzyme Technologies consolidated net profit rises 62.24% in the March 2026 quarter - Business Standard
Advanced Enzyme Technologies consolidated net profit rises 62.24% in the March 2026 quarter - Business Standard
Advanced Enzyme Technologies consolidated net profit rises 62.24% in the March 2026 quarter - Business Standard
Advanced Enzyme Technologies consolidated net profit rises 62.24% in the March 2026 quarter - Business Standard
Advanced Enzyme Technologies consolidated net profit rises 62.24% in the March 2026 quarter - Business Standard
Advanced Enzyme Technologies consolidated net profit rises 62.24% in the March 2026 quarter - Business Standard
Advanced Enzyme Technologies consolidated net profit rises 62.24% in the March 2026 quarter - Business Standard
Advanced Enzyme Technologies shares were last quoted at ₹266.00 (-0.4% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Advanced Enzyme Technologies has a price-to-earnings (P/E) ratio of 19.68 and a price-to-book (P/B) ratio of 1.95. The industry P/E is 53.33.
The 52-week high of Advanced Enzyme Technologies is ₹419.80 and the 52-week low is ₹251.90.
The market capitalisation of Advanced Enzyme Technologies is about ₹3,263.54 crore.
In the latest quarter (Jun 2026), Advanced Enzyme Technologies reported sales of ₹190.00 crore (+2.2%) and net profit of ₹39.00 crore (-2.5%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Advanced Enzyme Technologies has a 3-year ROE of 10.00%, 3-year profit growth of 12.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 43.24% of Advanced Enzyme Technologies.
Advanced Enzyme Technologies belongs to the Pharmaceuticals & Drugs sector.